Related Experiment Videos
[Tricyclic antidepressants in depressed patients with cardiovascular diseases: a contraindication?]
1Psychiatrische Klinik mit Poliklinik, Phillipps-Universität Marburg.
Insights
Tricyclic antidepressants can increase cardiovascular disease risk. This review details their cardiac effects, contraindications, and management strategies for patients with heart conditions.
Area of Science:
- Cardiology
- Psychiatry
- Clinical Pharmacology
Background:
- Depression and cardiovascular diseases frequently co-occur, particularly in older adults.
- Depression elevates cardiovascular disease risk, while cardiac conditions can precipitate treatable depression.
- Prescribing tricyclic antidepressants (TCAs) to cardiovascular patients presents significant clinical challenges.
Purpose of the Study:
- To review the cardiovascular effects of TCAs in healthy individuals and patients with cardiovascular diseases.
- To outline indications and contraindications for TCA use in patients with cardiovascular disorders.
- To propose diagnostic procedures and management strategies for TCA-related side effects.
Main Methods:
- Literature review of cardiovascular effects of TCAs.
- Analysis of clinical relevance for prescribing TCAs in cardiovascular disease patients.
- Synthesis of recommendations for managing TCA-induced side effects.
Main Results:
- TCAs exert notable cardiovascular effects in both healthy and diseased populations.
- Specific cardiovascular conditions influence the indications and contraindications for TCA therapy.
- Diagnostic and monitoring protocols are essential during TCA treatment.
Conclusions:
- Careful consideration of cardiovascular effects is crucial when prescribing TCAs.
- Tailored diagnostic and management approaches are necessary for patients with co-existing depression and cardiovascular disease.
- Recommendations are provided for optimizing TCA therapy and mitigating cardiovascular risks.
Abstract:
Depressive disorder and cardiovascular diseases occur quite frequently together in the same patient, especially in older patients. On the one hand depressions can increase the risk of cardiovascular diseases, on the other hand cardiac disease can lead to depressive disorders in need of treatment. Thus the problem of prescribing tricyclics for patients with cardiovascular diseases is of great clinical relevance. In our review we summarize first of all the important cardiovascular effects of tricyclics in healthy persons and patients with cardiovascular diseases. Indications and (relative) contraindications for this medication with respect to cardiovascular disorders and proposals for diagnostic procedures in the beginning and during the course of antidepressant medication are following. Finally we present some recommendations for the treatment of tricyclic-induced side effects.